Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Data Brief ; 53: 110236, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38445202

RESUMO

Higher education institutions are promoting the adoption of innovative methodologies and instructional approaches to engage and promote personalized learning paths to their students. Several strategies based on gamification, artificial intelligence, and data mining are adopted to create an interactive educational setting centred around students. Within this personalized learning environment, there is a notable boost in student engagement and enhanced educational outcomes. The MathE platform, an online educational system introduced in 2019, is specifically crafted to support students tackling difficulties in comprehending higher-education-level mathematics or those aspiring to deepen their understanding of diverse mathematical topics - all at their own pace. The MathE platform provides multiple-choice questions, categorized under topics and subtopics, aligning with the content taught in higher education courses. Accessible to students worldwide, the platform enables them to train their mathematical skills through these resources. When the students log in to the training area of the platform, they choose a topic to study and specify whether they prefer basic or advanced questions. The platform then selects a set of seven multiple-choice questions from the available ones under the chosen topic and generates a test for the student. After completing and submitting the test, the answers are recorded and stored on the platform. This paper describes the data stored in the MathE platform, focusing on the 9546 answers to 833 questions, provided by 372 students from 8 countries who use the platform to practice their skills using the questions (and other resources) available on the platform. The information in this paper will help research about active learning tools to support the improvement of future education, especially at higher educational level. Furthermore, these data are valuable for understanding student learning patterns, assessing platform efficacy, gaining a global perspective on mathematics education, and contributing to the advancement of active learning tools for higher education.

2.
Sensors (Basel) ; 24(2)2024 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-38257623

RESUMO

The accurate measurement of joint angles during patient rehabilitation is crucial for informed decision making by physiotherapists. Presently, visual inspection stands as one of the prevalent methods for angle assessment. Although it could appear the most straightforward way to assess the angles, it presents a problem related to the high susceptibility to error in the angle estimation. In light of this, this study investigates the possibility of using a new approach to angle calculation: a hybrid approach leveraging both a camera and LiDAR technology, merging image data with point cloud information. This method employs AI-driven techniques to identify the individual and their joints, utilizing the cloud-point data for angle computation. The tests, considering different exercises with different perspectives and distances, showed a slight improvement compared to using YOLO v7 for angle calculation. However, the improvement comes with higher system costs when compared with other image-based approaches due to the necessity of equipment such as LiDAR and a loss of fluidity during the exercise performance. Therefore, the cost-benefit of the proposed approach could be questionable. Nonetheless, the results hint at a promising field for further exploration and the potential viability of using the proposed methodology.


Assuntos
Terapia por Exercício , Fisioterapeutas , Humanos , Exercício Físico , Tecnologia , Extremidade Superior
3.
J Investig Med High Impact Case Rep ; 8: 2324709620977707, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33307837

RESUMO

Subacute invasive aspergillosis is an infection that locally destroys lung parenchyma, and it affects patients with mild immunocompromise. The diagnosis is made by clinical symptoms, imaging, and laboratory results related to the infection. Early diagnosis and treatment is imperative for a favorable patient outcome. In this article, we present the case of a 19-year-old woman who was admitted to the intensive care unit for puerperal sepsis where a hysterectomy was performed. During her hospitalization, she presented atelectasis of the left lung and hemodynamic instability. Chest X-ray and chest computed tomography scan were performed and showed round opacities. It was decided to perform flexible bronchoscopy with bronchoalveolar lavage. An unusual subacute form of implementation of aspergillosis was confirmed by a bronchoalveolar lavage culture that showed the presence of Aspergillus. Images taken during bronchoscopy revealed Aspergillus implantation in the lung and serum galactomannan antigen test was positive. Voriconazole was introduced, 200 mg daily. The patient showed clinical improvement and was discharged from our hospital. We conclude that subacute invasive aspergillosis is a serious infection that can lead to high mortality. Bronchoscopy with bronchoalveolar lavage allows access and effective visualization of the airway as well as sampling for Aspergillus identification.


Assuntos
Aspergillus/isolamento & purificação , Histerectomia/efeitos adversos , Aspergilose Pulmonar Invasiva/diagnóstico , Sepse/complicações , Antifúngicos/uso terapêutico , Líquido da Lavagem Broncoalveolar/microbiologia , Broncoscopia , Feminino , Humanos , Aspergilose Pulmonar Invasiva/tratamento farmacológico , Aspergilose Pulmonar Invasiva/microbiologia , Sepse/etiologia , Tomografia Computadorizada por Raios X , Voriconazol/uso terapêutico , Adulto Jovem
5.
Drugs ; 68(1): 73-83, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18081373

RESUMO

Currently, six medications are approved by the US FDA for the treatment of relapsing forms of multiple sclerosis (MS). In contrast, no pharmacological agent has proved to be effective in patients with secondary-progressive MS without relapses, or in patients with primary-progressive MS. One of the principal issues concerning an optimal pharmacotherapy for relapsing forms of MS is the optimal time of treatment initiation. There is now an almost universal consensus among MS experts that many patients will benefit from early therapy. However, several formidable challenges exist in identifying individuals who will benefit versus those who will do well without intervention. How do we define early MS and what clinical and paraclinical markers may be useful in defining the timing and nature of therapy? Do patients with a benign form of MS require therapy or are they exposed unnecessarily to adverse effects of our currently available medications? How do we identify disease progression and treatment failures? This review discusses these issues and outlines the evidence for application of 'early' treatment in patients with relapsing forms of MS.


Assuntos
Interferon beta/uso terapêutico , Esclerose Múltipla/tratamento farmacológico , Seleção de Pacientes , Progressão da Doença , Esquema de Medicação , Medicina Baseada em Evidências , Humanos , Interferon beta-1a , Interferon beta-1b , Interferon beta/administração & dosagem , Interferon beta/efeitos adversos , Esclerose Múltipla/diagnóstico , Guias de Prática Clínica como Assunto , Ensaios Clínicos Controlados Aleatórios como Assunto , Medição de Risco , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...